PHR · Phreesia, Inc.
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $30.5M | fiscal first quarter ended April 30, 2026 | — |
|
|
|||
| Average number of healthcare services clients ("AHSCs") | 4,708 | fiscal first quarter ended April 30, 2026 | — |
|
|
|||
| Free cash flow non-GAAP | $16.4M | fiscal first quarter ended April 30, 2026 | — |
|
|
|||
| Payment solutions revenue rate | 2.3% | Three months ended April 30, 2026 | — |
| Total managed payments | 1.79B | Three months ended April 30, 2026 | — |
| Total revenue per AHSC | $27,811 | fiscal first quarter ended April 30, 2026 | — |
|
|
|||
| Adjusted EBITDA margin non-GAAP | 23% | Q4 fiscal 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Health Information Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PHR
this stock
Phreesia, Inc.
|
$749.16M | -28.4% | +14.5% | 75.8 | 4.7% |
|
VEEV
Veeva Systems Inc
|
$40.27B | +11.1% | +28.1% | 44.0 | 4.5% |
|
TEM
Tempus AI, Inc.
|
$13.12B | +23.1% | +83.4% | — | 18.4% |
|
PMDIY
Pro Medicus Ltd./ADR
|
$13.02B | -24.9% | — | — | 0.0% |
|
BTSG
BrightSpring Health Services, Inc.
|
$11.65B | +57.2% | +28.2% | 35.7 | 4.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PHR | -1.3% | +18.6% | -1.2% | +13.0% | -28.4% |
| SPY | -1.4% | +3.6% | +11.6% | +2.5% | +12.3% |
| vs SPY | +0.1% | +15.0% | -12.8% | +10.5% | -40.7% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.